But because poor women cannot afford to get the vaccine, this disparity could become greater. American Journal of Preventive Medicine, 38(5), 525-533.
However, compulsory HPV vaccination could reduce the disease burden disparity by assuring all socioeconomic groups of women obtain the vaccine (Pruiit and Shootman, 2010).
Therefore, parents question whether there is justification for mandating that children be vaccinated against a sexually transmitted virus, one that can only be transmitted through sexual behavior (Cooper et al. Moreover, the vaccine only protects against the high-risk HPV types responsible for 70% of cervical cancers.
This incomplete protection does not reduce susceptibility to the other HPV types that cause the remaining 30% of cervical cancers and will still require females to undergo yearly cervical cancer screenings and to practice other preventive measures of reducing STI exposure (American Social Health Association, 2006).
This vaccine has proven to be one-hundred percent effective in preventing the 4 HPV strains that are responsible for seventy percent of cervical cancers and ninety percent of genital warts.
In addition, no serious side effects have been identified.
Currently, the vaccine appears to be effective for only 5 years.
Unfortunately, not all possible side effects of the vaccine have been determined, and since the approval of Gardasil, at least 82 adverse events have occurred including nausea, fever, rashes, and fainting spells (Gottvall et al. Other questions and unknowns exist about the HPV vaccine. What, if any, are the short-term or long-term impacts of the vaccine on fertility or pregnancy intention?Mandating the HPV Vaccination: A Controversial Debate Background: The Human papillomavirus (HPV) is the virus responsible for cervical cancer.It is one the most common viral sexually transmitted infections.Reports in Canada show that 8 out of 10 Canadians will have at least one HPV infection in their lives.While most of these infections will go away on their own, some may not.A vaccine was approved in 2006 that is effective in preventing the types of HPV responsible for 70% of cervical cancers and 90% of genital warts.